Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CHAIRMAN TO TAKE MEDICAL LEAVE OF ABSENCE

28th Apr 2017 08:11

RNS Number : 6598D
Spectris PLC
28 April 2017
 

 

 

 

 

 

Spectris plc

CHAIRMAN TO TAKE MEDICAL LEAVE OF ABSENCE

28 April 2017 - The Board of Spectris plc ('Spectris') (LSE: SXS), the productivity-enhancing instrumentation and controls company, announces that Dr John Hughes, non-executive Chairman, has taken leave of absence in order to undergo medical treatment. Russell King, Senior Independent Director, will assume the Chair until John's return or the appointment of his successor on completion of the recruitment process which was announced on 5 December 2016.

 

 

- ENDS -

Contacts:

 

Spectris plc

Siobhán Andrews, Head of Corporate Affairs

+44 1784 470470

FTI Consulting

Richard Mountain/Susanne Yule

+44 203 727 1340

 

 

ABOUT SPECTRIS

Spectris plc is a leading supplier of productivity-enhancing instrumentation and controls. The Company's products and technologies help customers to improve product quality and performance, improve core manufacturing processes, reduce downtime and wastage and reduce time to market. Its global customer base spans a diverse range of end user markets. Spectris operates across four business segments which reflect the applications and industries it serves: Materials Analysis, Test and Measurement, In-line Instrumentation and Industrial Controls. Headquartered in Egham, Surrey, United Kingdom, the Company employs around 8,900 people with offices in more than 30 countries. For more information, visit www.spectris.com (http://www.spectris.com).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEWSWAFWSESL

Related Shares:

Spectris
FTSE 100 Latest
Value8,275.66
Change0.00